<bill session="110" type="s" number="976" updated="2009-01-09T13:47:52-05:00">
	<status><introduced date="1174622400" datetime="2007-03-23"/></status>

	<introduced date="1174622400" datetime="2007-03-23"/>
	<titles>
		<title type="short" as="introduced">Genomics and Personalized Medicine Act of 2007</title>
		<title type="official" as="introduced">A bill to secure the promise of personalized medicine for all Americans by expanding and accelerating genomics research and initiatives to improve the accuracy of disease diagnosis, increase the safety of drugs, and identify novel treatments.</title>
	</titles>
	<sponsor id="400629"/>
	<cosponsors>
		<cosponsor id="400272" joined="2008-07-31"/>
		<cosponsor id="400054" joined="2007-03-23"/>
	</cosponsors>
	<actions>
		<action date="1174622400" datetime="2007-03-23"><text>Sponsor introductory remarks on measure. (CR S3708-3710)</text></action>
		<action date="1174622400" datetime="2007-03-23"><text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text></action>
	</actions>
	<committees>

	</committees>
	<relatedbills>

	</relatedbills>
	<subjects>

	</subjects>
	<amendments>

	</amendments>
	<summary>
	3/23/2007--Introduced.<br/>Genomics and Personalized Medicine Act of 2007 - Directs the Secretary of Health and Human Services to: (1) establish the Genomics and Personalized Medicine Interagency Working Group (IWG) to facilitate collaboration, coordination, and integration of activities among federal agencies relating to genomic research and initiatives; (2) establish a national biobanking distributed database for the collection and integration of genomic data and associated environmental and clinical health information; (3) establish a grant program for academic medical centers and other entities to develop or expand biobanking initiatives; (4) improve genetics and genomics training for diagnosis, treatment, and counseling of adults and children for both rare and common disorders; (5) contract with the National Academy of Sciences to study incentives to encourage companion diagnostic test development; and (6) make information available on the safety and efficacy of genetic tests and commission a study for improving federal oversight and regulation of such tests. Requires the Director of the Centers for Disease Control and Prevention to: (1) conduct an analysis of the public health impact of direct-to-consumer marketing of genetic tests; and (2) expand efforts to educate the public about genomics and its health applications.<br/>
	</summary>
</bill>
